Trials / Completed
CompletedNCT04530539
The Effect of Melatonin and Vitamin C on COVID-19
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Lancaster General Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
This is a double-blind placebo controlled trial that seeks to evaluate the impact of melatonin and vitamin C on symptoms and outcomes of patients with COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin C | 1000mg Vitamin C, at bedtime |
| DIETARY_SUPPLEMENT | melatonin | 10mg melatonin, at bedtime |
| DIETARY_SUPPLEMENT | Placebo | Placebo at bedtime |
| OTHER | Symptom Survey | Daily symptom survey to be completed by patient electronically |
Timeline
- Start date
- 2020-10-05
- Primary completion
- 2022-08-11
- Completion
- 2022-08-11
- First posted
- 2020-08-28
- Last updated
- 2022-08-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04530539. Inclusion in this directory is not an endorsement.